A Study of the Reaction Product of Factor VIII and Factor IX by Gel Filtration

C Hougie; K. W. E Denson; Rosemary Biggs

doi:10.1055/s-0038-1655030

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1967; 18(01/02): 211-222
DOI: 10.1055/s-0038-1655030

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

A Study of the Reaction Product of Factor VIII and Factor IX by Gel Filtration^[*]

C Hougie

¹MRC Coagulation Unit, Oxford, England, and Department of Pathology, University of Washington Seattle, Washington

,

K. W. E Denson

¹MRC Coagulation Unit, Oxford, England, and Department of Pathology, University of Washington Seattle, Washington

,

Rosemary Biggs

¹MRC Coagulation Unit, Oxford, England, and Department of Pathology, University of Washington Seattle, Washington

› Institutsangaben

Abstract

Summary

The products of the reaction of activated factor IX with factor VIII, phospholipid and calcium have been studied using gel filtration on Sephadex G-200. Both factor VIII and phospholipid are completely excluded from the gel (distribution coefficient or KD of zero) while factor IX_a behaves like a protein similar in size to albumin (KD approx. 0.4). Factor IX_a complexes with phospholipid when calcium ions are added to the eluting buffer. When factor VIII, factor IX_a, phospholipid and calcium are applied to the column and eluted with added Ca⁺⁺ in the eluting buffer, a labile product with a KD of 0 is formed. The product apparently dissociates in the absence of added calcium ions in the eluting buffer. In the presence of calcium ions, the distribution coefficient of factor IX, when applied alone to the column, increased. The above findings are analogous to those reported between activated factor X, thrombin-activated factor V, phospholipid and calcium occurring later in the coagulation process.

Volltext

Referenzen

References
1 Macfarlane R. G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature (Lond) 202: 498 1964;
2 Davie E. W, Ratnoff O. D. Waterfall sequence for intrinsic blood clotting. Science 145: 1310 1964;
3 Davie E. W, Ratnoff O. D. The Proteins of Blood Coagulation. The Proteins. 03: 359 1965;
4 Macfarlane R. G. Observations on the Interaction of Factors VIII, IX and X. Thrombos. Diathes. haemorrh. (Stuttg.) 9 Suppl. 02: 221 1963;
5 Sjpaet T. H, Cintron J. Pathways to Blood Coagulation Product I Formation. Blood. 21: 745 1963;
6 Macfarlane R. G, Biggs R, Ash B. J, Denson K. W. E. The activation and consumption of factor X in recalcified plasma. The effect of added Factor VIII and Russell’s viper venom. Brit. J. Haemat. 10: 530 1964;
7 Hougie G. Sequential Reactions of Factors VIII, IX, and X. In: Hemophilioid Diseases. 3d. ed. 225 Brinkhous K. M. ed. University of North Carolina Press; Chapel Hill: 1964
8 Lundblad R. L, Davie E. W. The activation of antihemophilic factor (factor VIII) by activated Christmas factor (activated factor IX). Biochemistry 03: 1720 1964;
9 Lundblad R. L, Davie E. W. The activation of Stuart factor (factor X) by activated antihemophilic factor (activated factor VIII). Biochemistry 04: 113 1965;
10 Lundblad R. L, Thesis Ph. D. The stepwise activation of antihemophilic factor and Stuart factor during normal blood coagulation. University of Washington; 1965.:
11 Biggs R, Macfarlane R. G, Denson K. W. E, Ash B. J. The interaction of factors VIII and IX. Brit. J. Haemat. 11: 276 1965;
12 Macfarlane R. G. The coagulant action of Russell’s viper venom; The use of antivenom in defining its reaction with a serum factor. Brit. J. Haemat. 07: 496 1961;
13 Esnouf M. P, Williams W. J. The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell’s viper venom. Biochemistry 84: 62 1962;
14 Pechet L, Alexander B. Activation of Prothrombin, Factors VII and X by Proteolytic Pathway. Fed. Proc. 19: 64 1960;
15 Alexander B, Pechet L, Kliman A. Proteolysis, Fibrinolysis and Coagulation Significance in Thrombolytic Therapy. Circulation 26: 596 1962;
16 Ferguson J. H, Ennis E. G. W. Enzymes and blood clotting. II. Auto prothrombin C, Russell’s viper venom (stypven) and trypsin. Thrombos. Diathes. haemorrh. (Stuttg) 09: 62 1962;
17 Yin E. T. Kinetics of Human Blood Coagulation Induced by Trypsin. Thrombos. Diathes. haemorrh. (Stuttg) 12: 307 1964;
18 Papahadjopoulos D, Hougie C, Hanahan D. J. Purification and properties of bovine factor V: A change of molecular size during blood coagulation. Biochemistry 03: 264 1964;
19 Lewis J. H. Effects of epsilon amino caproic acid (EACA) on survival of fibrinogen 1-131 and on fibrinolytic and coagulation factors in dogs. Proc. Soc. exp. Biol. (N. Y) 116: 120 1964;
20 Folch J. Brain cephalin mixture of phosphatides. Separation from it of phosphatidyl serine, phosphatidyl ethanolamine and fraction containing inositol phosphatide. J. biol. Chem. 146: 35 1942;
21 Biggs R, Macfarlane R. G. Human Blood Coagulation and its Disorders. 3d. ed. Blackwell Scientific Publications Oxford; 1962
22 Bell W. M, Alton H. G. Brain extract as substitute for platelet suspensions in thromboplastin generation test. Nature (Lond) 174: 880 1954;
23 Gornall A. G, Bardawill C. J, David M. M. Determination of serum proteins by means of biuretreaction. J. biol. Chem. 177: 751 1949;
24 Denson K. W. The specific assay of Prower-Stuart factor and factor VII biuret reaction. Acta haemat. (Basel) 25: 105 1961;
25 Langdell R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting tests: Presumptive test for hemophilia and simple one-stage antihemophilic factor assay procedure. J. Lab. clin. Med. 41: 637 1953;
26 Proctor R. R, Rapaport S. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Amer. J. clin. Path. 36: 212 1961;
27 Bidwell E. Purification of bovine antihaemophilic globulin. Brit. J. Haemat. 01: 35 1955;
28 Bidwell E, Dike G. W. R, Denson K. W. E. Experiments with Factor VIII Separated from Fibrinogen by Electrophoresis in Free Buffer Film. Brit. J. Haemat. 12: 583-594 1966;
29 Bell W. M, Alton H. G. Brain extract as substitute for platelet suspensions in thromboplastin generation test. Nature (Lond) 174: 880 1954;
30 Gornall A. G, Bardawill G. J, David M. M. Determination of serum proteins by means of biuret reaction. J. biol. Chem. 177: 751 1949;
31 Denson K. W. The specific assay of Prower-Stuart factor and factor VII biuret reaction. Acta haemat. (Basel) 25: 105 1961;
32 Langdell R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one stage clotting tests: Presumptive test for hemophilia and simple one-stage antihemophilic factor assay procedure. J. Lab. clin. Med. 41: 637 1953;
33 Proctor R. R, Rapaport S. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Amer. J. clin. Path. 36: 212 1961;
34 Bidwell E. Purification of bovine antihaemophilic globulin. Brit. J. Haemat. 01: 35 1955;
35 Bidwell E, Dike G. W. R, Denson K. W. E. Experiments with Factor VIII Separated from Fibrinogen by Electrophoresis in Free Buffer Film. Brit. J. Haemat. 12: 583 1966;
36 Denson K. W. D. Phil. Thesis. University of Oxford; 1966
37 Esnouf M. P, Williams W. J. The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell’s viper venom. Biochem. J. 84: 62 1962;
38 Nossel H. L. In: The Contact Phase of Blood Coagulation. 124-128 Blackwell Scientific Publications Oxford; 1964
39 Flodin P, Killander J. Fractionation of Human-Serum Proteins by Gel Filtration. Biochim. biophys. Acta (Amst) 63: 403 1962;
40 Flodin P. Methodoligical aspects of gel filtration with special reference to desalting operations. J. Chromatog. 05: 103 1961;
41 Papahadjopoulos D. D. Phil. Thesis: Studies in Blood Coagulation, Interactions between Proteins and Lipids. University of Washington; 1963
42 Hanahan D. J, Papahadjopoulos D. Interactions of Phospholipids with Coagulation Factors. Conf. Int. Comm. Blood Clot. Factors, Amsterdam, 71 1964;
43 Denson K. W. D. Phil. Thesis: University of Oxford; 1966
44 Esnouf M. P, Williams W. J. The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell’s viper venom. Biochem. J. 84: 62 1962;
45 Nossel H. L. In: The Contact Phase of Blood Coagulation. 124-128 Blackwell Scientific Publications Oxford; 1964
46 Flodin P, Killander J. Fractionation of Human-Serum Proteins by Gel Filtration. Biochim. biophys. Acta (Amst) 63: 403 1962;
47 Flodin P. Methodological aspects of gel filtration with special reference to desalting operations. J. Chromatog. 05: 103 1961;
48 Papahadjopoulos D. D. Phil. Thesis: Studies in Blood Coagulation, Interactions between Proteins and Lipids. University of Washington. 1963
49 Hahan D. J, Papahadjopoulos D. Interactions of Phospholipids with Coagulation Factors. Conf. Int. Comm. Blood Clot. Factors, Amsterdam, 71 1964;
50 Breckenridge R. T, Ratnojf O. D. The role of proaccelerin in human blood coagulation. Evidence that proaccelerin is converted to a prothrombin-converting principle by activated Stuart factor: With notes on the anticoagulant action of soybean, trypsin inhibitor, protamine sulfate and hexadimethrine bromide. J. clin. Invest. 44: 302 1965;
51 Esnouf M. P, Jobin F. Lipids in Prothrombin Conversion. Conf. Int. Comm. Blood Clot. Factors, Amsterdam, 103 1964;

A Study of the Reaction Product of Factor VIII and Factor IX by Gel Filtration[*]

A Study of the Reaction Product of Factor VIII and Factor IX by Gel Filtration^[*]